• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性与人类乳头瘤病毒相关的疾病:沉重的可通过疫苗预防的负担。

HPV related diseases in males: a heavy vaccine-preventable burden.

作者信息

Canepa P, Orsi A, Martini M, Icardi G

机构信息

Department of Health Sciences, University of Genoa, Italy.

出版信息

J Prev Med Hyg. 2013 Jun;54(2):61-70.

PMID:24396983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4718386/
Abstract

Human Papillomavirus (HPV) has a significant impact in male's health, as cause of clinical manifestations ranging from genital warts to several cancers of the anogenital and aero-digestive tract. HPV types which most frequently affect men are 6, 11, 16 and 18, included in the HPV quadrivalent vaccine, recently approved for use in males by Food and Drug Administration (FDA) and European Medicines Agency (EMA). Although several data about the safety and efficacy of quadrivalent vaccine are available, the implementation of proper immunization plans dedicate to male's population cannot ignore the knowledge of the characteristics of the disease in men, which in some aspects should be clarify, in particular clearance of type-specific HPV infections and transmission dynamics. Purpose of this review is to summarise the main information about the burden and the natural history of the HPV related disease in males.

摘要

人乳头瘤病毒(HPV)对男性健康有重大影响,可导致从尖锐湿疣到多种肛门生殖器和上呼吸道消化道癌症等一系列临床表现。最常感染男性的HPV类型为6型、11型、16型和18型,这些都包含在HPV四价疫苗中,该疫苗最近已获美国食品药品监督管理局(FDA)和欧洲药品管理局(EMA)批准用于男性。尽管已有若干关于四价疫苗安全性和有效性的数据,但制定针对男性人群的适当免疫计划不能忽视对男性疾病特征的了解,其中某些方面仍需阐明,特别是特定类型HPV感染的清除情况和传播动态。本综述的目的是总结有关男性HPV相关疾病负担和自然史的主要信息。

相似文献

1
HPV related diseases in males: a heavy vaccine-preventable burden.男性与人类乳头瘤病毒相关的疾病:沉重的可通过疫苗预防的负担。
J Prev Med Hyg. 2013 Jun;54(2):61-70.
2
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.四价人乳头瘤病毒(HPV)疫苗在男性中的功效、免疫原性和安全性:一项随机、安慰剂对照、3 期临床试验的开放标签、长期扩展的结果。
Lancet Infect Dis. 2022 Mar;22(3):413-425. doi: 10.1016/S1473-3099(21)00327-3. Epub 2021 Nov 12.
3
Getting to know human papillomavirus (HPV) and the HPV vaccines.了解人乳头瘤病毒(HPV)及HPV疫苗。
J Am Osteopath Assoc. 2011 Mar;111(3 Suppl 2):S29-34.
4
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?澳大利亚 HPV 疫苗接种 10 年的影响:九价疫苗将预防哪些额外的疾病负担?
Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700737.
5
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.评估在欧洲为男童和女童接种 HPV 相关疾病疫苗的临床获益。
BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.
6
Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.挪威人乳头瘤病毒疫苗从二价转换为九价的公共卫生影响及成本效益:纳入所有HPV相关疾病的全面健康影响
J Med Econ. 2023 Jan-Dec;26(1):1085-1098. doi: 10.1080/13696998.2023.2250194.
7
Human papillomavirus vaccination in males.男性人乳头瘤病毒疫苗接种
Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S24-6. doi: 10.1016/j.ygyno.2007.07.075.
8
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.24至45岁女性四价人乳头瘤病毒(6、11、16、18型)重组疫苗的安全性、免疫原性及有效性:一项随机双盲试验
Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1.
9
[What should be known for the introduction of an HPV vaccine?].[引入人乳头瘤病毒疫苗时应了解哪些内容?]
Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10.
10
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.不同人乳头瘤病毒(HPV)疫苗类型及接种程序对预防女性和男性HPV相关疾病的比较。
Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479.

引用本文的文献

1
Impact of gender and education on cervical cancer knowledge amongst students: implications for health policies and public health strategies in Wiesbaden, Germany.性别和教育对德国威斯巴登学生宫颈癌知识的影响:对卫生政策和公共卫生策略的启示。
J Prev Med Hyg. 2024 Aug 31;65(2):E227-E231. doi: 10.15167/2421-4248/jpmh2024.65.2.3077. eCollection 2024 Jun.
2
Analogies between HPV Behavior in Oral and Vaginal Cavity: Narrative Review on the Current Evidence in the Literature.口腔与阴道中HPV行为的类比:文献中当前证据的叙述性综述
J Clin Med. 2024 Mar 1;13(5):1429. doi: 10.3390/jcm13051429.
3
HPV-related diseases in male patients: an underestimated conundrum.男性患者的 HPV 相关疾病:一个被低估的难题。
J Endocrinol Invest. 2024 Feb;47(2):261-274. doi: 10.1007/s40618-023-02192-3. Epub 2023 Sep 28.
4
Impact of Human Papillomavirus Vaccination on Male Disease: A Systematic Review.人乳头瘤病毒疫苗对男性疾病的影响:一项系统评价
Vaccines (Basel). 2023 Jun 9;11(6):1083. doi: 10.3390/vaccines11061083.
5
Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment.在尼日利亚西南部伊巴丹的一些社区中,青少年对人乳头瘤病毒疫苗接种的偏好选择:一项离散选择实验。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2124091. doi: 10.1080/21645515.2022.2124091. Epub 2022 Nov 16.
6
Facilitators and barriers of healthcare workers' recommendation of HPV vaccine for adolescents in Nigeria: views through the lens of theoretical domains framework.促进和阻碍尼日利亚医护人员推荐 HPV 疫苗给青少年的因素:基于理论领域框架的观点。
BMC Health Serv Res. 2022 Jun 25;22(1):824. doi: 10.1186/s12913-022-08224-7.
7
Buschke-Loewenstein Tumor: A Case Report and Advocacy for Human Papillomavirus Vaccination.Buschke-Loewenstein肿瘤:一例报告及对人乳头瘤病毒疫苗接种的倡导
Cureus. 2020 Oct 4;12(10):e10789. doi: 10.7759/cureus.10789.
8
Factors Associated with HPV Vaccination in Young Males.男性青少年 HPV 疫苗接种相关因素。
J Community Health. 2017 Dec;42(6):1127-1132. doi: 10.1007/s10900-017-0361-4.

本文引用的文献

1
Economic burden of human papillomavirus-related diseases in Italy.意大利人乳头瘤病毒相关疾病的经济负担。
PLoS One. 2012;7(11):e49699. doi: 10.1371/journal.pone.0049699. Epub 2012 Nov 21.
2
Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.尽管长期联合抗逆转录病毒治疗,但 HIV 相关肛门癌的发病率仍在增加:来自法国 HIV 医院数据库的结果。
J Clin Oncol. 2012 Dec 10;30(35):4360-6. doi: 10.1200/JCO.2012.44.5486. Epub 2012 Oct 22.
3
HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues.人乳头瘤病毒感染、肛门上皮内瘤变(AIN)和肛门癌:当前问题。
BMC Cancer. 2012 Sep 8;12:398. doi: 10.1186/1471-2407-12-398.
4
Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.瑞典四价人乳头瘤病毒疫苗供应前后生殖器疣发病率。
J Infect Dis. 2012 Sep 15;206(6):860-6. doi: 10.1093/infdis/jis405. Epub 2012 Jul 18.
5
Genital human papillomavirus (HPV) concordance in heterosexual couples.异性恋伴侣间的生殖器人乳头瘤病毒(HPV)一致性。
J Infect Dis. 2012 Jul 15;206(2):202-11. doi: 10.1093/infdis/jis327. Epub 2012 Apr 26.
6
Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.男男性行为者接种四价人乳头瘤病毒疫苗预防复发性高级别肛门肿瘤:一项非同期队列研究。
Clin Infect Dis. 2012 Apr;54(7):891-8. doi: 10.1093/cid/cir1036. Epub 2012 Jan 30.
7
Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.欧洲男性人乳头瘤病毒相关癌症和非恶性疾病的流行病学负担估计:综述。
BMC Cancer. 2012 Jan 20;12:30. doi: 10.1186/1471-2407-12-30.
8
Incidence of human papillomavirus infection in male sexual partners of women diagnosed with CIN II-III.人乳头瘤病毒感染在女性宫颈上皮内瘤变 II-III 级患者男性性伴中的发生率。
Eur J Dermatol. 2012 Mar-Apr;22(2):200-4. doi: 10.1684/ejd.2011.1622.
9
Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.巴西、墨西哥和美国男性的人乳头瘤病毒感染的种族和流行率。
Int J Cancer. 2012 Aug 1;131(3):E282-91. doi: 10.1002/ijc.27397. Epub 2012 Jan 11.
10
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.HPV 疫苗预防肛门 HPV 感染和肛门上皮内瘤变。
N Engl J Med. 2011 Oct 27;365(17):1576-85. doi: 10.1056/NEJMoa1010971.